AU Patent

AU2008254500B2 — Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof

Assigned to Atnx Spv LLC United States · Expires 2014-01-23 · 12y expired

What this patent protects

The invention relates to compositions comprising 2-(5-(4-(2- morpholinoethoxy)phenyl)pyτidin-2-yl)--V-benzylacetamide and its mesylate and dihydrochloride salts. More specifically, the invention provides an efficient process for the synthesis of 2-(5-<4-(2-morpholinoethoxy)phe…

USPTO Abstract

The invention relates to compositions comprising 2-(5-(4-(2- morpholinoethoxy)phenyl)pyτidin-2-yl)--V-benzylacetamide and its mesylate and dihydrochloride salts. More specifically, the invention provides an efficient process for the synthesis of 2-(5-<4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-ΛΛbenzylacetainide and its mesylate and dihydrochloride salts and methods for modulating one or more components of a kinase cascade using the compositions of the invention.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008254500B2
Jurisdiction
AU
Classification
—
Expires
2014-01-23
Drug substance claim
No
Drug product claim
No
Assignee
Atnx Spv LLC United States
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.